Atai Life Sciences Net Profit Margin 2020-2025 | ATAI
Atai Life Sciences Net Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Net Income | Net Margin |
2025-03-31 | $0.00B | $-0.15B | -7400.00% |
2024-09-30 | $0.00B | $-0.13B | 0.00% |
2024-06-30 | $0.00B | $-0.06B | 0.00% |
2023-12-31 | $0.00B | $-0.04B | 0.00% |
2023-09-30 | $0.00B | $-0.07B | 0.00% |
2023-06-30 | $0.00B | $-0.15B | 0.00% |
2023-03-31 | $0.00B | $-0.15B | 0.00% |
2022-09-30 | $0.00B | $-0.20B | 0.00% |
2022-06-30 | $0.00B | $-0.19B | 0.00% |
2021-12-31 | $0.02B | $-0.17B | -835.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical - Outpatient & Home Care | $0.531B | $0.000B |
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Quest Diagnostics (DGX) | United States | $18.578B | 18.31 |
Encompass Health (EHC) | United States | $10.813B | 22.92 |
DaVita (DVA) | United States | $10.610B | 14.92 |
Elanco Animal Health (ELAN) | United States | $7.256B | 15.54 |
Chemed (CHE) | United States | $6.638B | 20.86 |
Option Care Health (OPCH) | United States | $5.034B | 22.44 |
RadNet (RDNT) | United States | $4.161B | 264.10 |
Amedisys (AMED) | United States | $3.200B | 21.52 |
Addus HomeCare (ADUS) | United States | $2.013B | 22.11 |
LifeStance Health (LFST) | United States | $1.711B | 0.00 |
Astrana Health (ASTH) | United States | $1.373B | 34.01 |
U.S Physical Therapy (USPH) | United States | $1.111B | 28.69 |
Pennant (PNTG) | United States | $0.843B | 30.96 |
Aveanna Healthcare Holdings (AVAH) | United States | $0.788B | 44.89 |
Daxor (DXR) | United States | $0.046B | 0.00 |
MEDIROM Healthcare Technologies (MRM) | Japan | $0.039B | 0.00 |
Ontrak (OTRK) | United States | $0.002B | 0.00 |
Psychemedics (PMD) | United States | $0.000B | 0.00 |